paliperidone palmitate
Drug Details
- Generic Name
- paliperidone palmitate
- Brand Names
- Erzofri extended-release, INVEGA HAFYERA, INVEGA SUSTENNA, INVEGA TRINZA
- Application Number
- NDA216352
- Sponsor
- Shandong Luye Pharmaceutical Co., Ltd.
- NDC Codes
- 17
- Dosage Forms
- INJECTION, INJECTION, SUSPENSION, EXTENDED RELEASE
- Routes
- INTRAMUSCULAR
- Active Ingredients
- PALIPERIDONE PALMITATE
Indications and Usage
1 INDICATIONS AND USAGE INVEGA TRINZA (paliperidone palmitate), a 3-month injection, is indicated for the treatment of schizophrenia in patients after they have been adequately treated with INVEGA SUSTENNA (1-month paliperidone palmitate extended-release injectable suspension) for at least four months [see Dosage and Administration (2.2) and Clinical Studies (14) ] . INVEGA TRINZA, a 3-month injection, is an atypical antipsychotic indicated for the treatment of schizophrenia in patients after they have been adequately treated with INVEGA SUSTENNA (1-month paliperidone palmitate extended-release injectable suspension) for at least four months. ( 1 )